Nutritional disorder
Rare disease
No
- Definition
- Any condition related to a disturbance between proper intake and utilization of nourishment.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Nutritional disorder
- nutritional disorder
- Nutritional Disease
- Nutritional Disorders
- Severity
- Unknown
- MONDO ID
- MONDO:0005137
- Parent condition
- MONDO:7770008
Related records
Broader conditions (3)
- Disease
- Disease by etiologic mechanism
- Human disease
Narrower conditions (109)
- Abdominal obesity-metabolic syndrome
- Abdominal obesity-metabolic syndrome 3
- Abdominal obesity-metabolic syndrome 4
- Abdominal obesity-metabolic syndrome quantitative trait locus 2
- Acquired night blindness
- Alcohol-induced Wernicke-Korsakoff's syndrome
- Anorexia nervosa
- Ariboflavinosis
- Avoidant/restrictive food intake disorder
- Beriberi
- Binge eating disorder
- Bulimia nervosa
- Cerebral folate deficiency
- Choline deficiency disease
- Disorders of vitamin D metabolism
- Dry beriberi
- Eating disorder
- Endemic goiter
- Epilepsy, early-onset, vitamin B6-dependent
- Familial isolated deficiency of vitamin E
Trials (449)
- 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)
- A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
- A Common Elements-based Intervention to Improve Maternal Psychological Well-being and Mother-infant Interaction
- A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
- A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
- A Nutrition/Hygiene Education Program for the Prevention of Child Malnutrition in Rural Kenya
- A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity
- A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
- A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
- A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
- A Retrospective Analysis of Percutaneous Endoscopic Gastrostomy Experiences
- A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
- A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
- A Study of the Safety of R256918 in Obese Patients
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
Drugs in development (10)
- Avexitide Phase 1
- Cagrilintide Phase 1
- Lactisole sodium Phase 1
- Lidocaine Phase 3
- Liraglutide Phase 3
- Omega-3 fatty acids Phase 2
- Oxycodone Phase 2
- Pectin Phase 1
- Semaglutide Phase 3
- Sodium chloride Phase 1